TotalMarketCap

Equillium

EQNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$103.834 M

$1.33 -5.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Equillium (EQ) has a market capitalization of $103.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$41.1M

#2777 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

63,408,082

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #287NovaBridge BiosciencesNBP$104.8M
  2. #288TuHURA BiosciencesHURA$103.9M
  3. #289EquilliumEQ$103.8M
  4. #290OnKure TherapeuticsOKUR$102.3M
  5. #291CellectisCLLS$101.5M

What if Equillium were worth as much as…

Open the what-if tool →

Gold $28.2T

$360,323.49

Per share 271,942× higher

Bitcoin $1.53T

$19,496.48

Per share 14,714× higher

Apple $5.02T

$64,005.11

Per share 48,306× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Equillium are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.